Literature DB >> 14694130

Imparting temperature sensitivity and attenuation in ferrets to A/Puerto Rico/8/34 influenza virus by transferring the genetic signature for temperature sensitivity from cold-adapted A/Ann Arbor/6/60.

Hong Jin1, Helen Zhou, Bin Lu, George Kemble.   

Abstract

The four temperature-sensitive (ts) loci identified in the PB1 and PB2 gene segments of cold-adapted A/Ann Arbor/6/60 influenza virus, the master donor virus for influenza A virus (MDV-A) FluMist vaccines, were introduced into a divergent A/Puerto Rico/8/34 influenza virus strain. Recombinant A/Puerto Rico/8/34 virus with these four introduced ts loci exhibited both ts and att phenotypes similar to those of MDV-A, which could be used as a donor virus for manufacturing large quantities of inactivated influenza virus vaccine against potential pandemic strains.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14694130      PMCID: PMC368857          DOI: 10.1128/jvi.78.2.995-998.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  19 in total

Review 1.  Principles underlying the development and use of live attenuated cold-adapted influenza A and B virus vaccines.

Authors:  Brian R Murphy; Kathleen Coelingh
Journal:  Viral Immunol       Date:  2002       Impact factor: 2.257

2.  A DNA transfection system for generation of influenza A virus from eight plasmids.

Authors:  E Hoffmann; G Neumann; Y Kawaoka; G Hobom; R G Webster
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

3.  Multiple amino acid residues confer temperature sensitivity to human influenza virus vaccine strains (FluMist) derived from cold-adapted A/Ann Arbor/6/60.

Authors:  Hong Jin; Bin Lu; Helen Zhou; Chienhui Ma; Jackie Zhao; Chin-fen Yang; George Kemble; Harry Greenberg
Journal:  Virology       Date:  2003-02-01       Impact factor: 3.616

4.  Future influenza vaccines and the use of genetic recombinants.

Authors:  E D Kilbourne
Journal:  Bull World Health Organ       Date:  1969       Impact factor: 9.408

5.  Functional analysis of PA binding by influenza a virus PB1: effects on polymerase activity and viral infectivity.

Authors:  D R Perez; R O Donis
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

6.  Recombination of influenza A virus strains: effect on pathogenicity.

Authors:  F A Ennis; M Verbonitz; P Reichelderfer; S Daniel
Journal:  Dev Biol Stand       Date:  1976

7.  Eight-plasmid system for rapid generation of influenza virus vaccines.

Authors:  Erich Hoffmann; Scott Krauss; Daniel Perez; Richard Webby; Robert G Webster
Journal:  Vaccine       Date:  2002-08-19       Impact factor: 3.641

8.  Trials in man with live recombinants made from A/PR/8/34 (H0 N1) and wild H3 N2 influenza viruses.

Authors:  A S Beare; G C Schild; J W Craig
Journal:  Lancet       Date:  1975-10-18       Impact factor: 79.321

9.  Mortality associated with influenza and respiratory syncytial virus in the United States.

Authors:  William W Thompson; David K Shay; Eric Weintraub; Lynnette Brammer; Nancy Cox; Larry J Anderson; Keiji Fukuda
Journal:  JAMA       Date:  2003-01-08       Impact factor: 56.272

10.  A single amino acid mutation in the PA subunit of the influenza virus RNA polymerase inhibits endonucleolytic cleavage of capped RNAs.

Authors:  Ervin Fodor; Mandy Crow; Louise J Mingay; Tao Deng; Jane Sharps; Pierre Fechter; George G Brownlee
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

View more
  52 in total

1.  Interplay of PA-X and NS1 Proteins in Replication and Pathogenesis of a Temperature-Sensitive 2009 Pandemic H1N1 Influenza A Virus.

Authors:  Aitor Nogales; Laura Rodriguez; Marta L DeDiego; David J Topham; Luis Martínez-Sobrido
Journal:  J Virol       Date:  2017-08-10       Impact factor: 5.103

2.  Oral retinyl palmitate or retinoic acid corrects mucosal IgA responses toward an intranasal influenza virus vaccine in vitamin A deficient mice.

Authors:  S L Surman; B G Jones; R E Sealy; R Rudraraju; J L Hurwitz
Journal:  Vaccine       Date:  2014-03-21       Impact factor: 3.641

3.  Engineering temperature sensitive live attenuated influenza vaccines from emerging viruses.

Authors:  Bin Zhou; Yan Li; Scott D Speer; Anju Subba; Xudong Lin; David E Wentworth
Journal:  Vaccine       Date:  2012-03-24       Impact factor: 3.641

4.  Tyr82 Amino Acid Mutation in PB1 Polymerase Induces an Influenza Virus Mutator Phenotype.

Authors:  Tadasuke Naito; Kazumasa Shirai; Kotaro Mori; Hidetaka Muratsu; Hiroshi Ushirogawa; Ryosuke L Ohniwa; Kousuke Hanada; Mineki Saito
Journal:  J Virol       Date:  2019-10-29       Impact factor: 5.103

5.  Temperature-Sensitive Live-Attenuated Canine Influenza Virus H3N8 Vaccine.

Authors:  Aitor Nogales; Laura Rodriguez; Caroline Chauché; Kai Huang; Emma C Reilly; David J Topham; Pablo R Murcia; Colin R Parrish; Luis Martínez-Sobrido
Journal:  J Virol       Date:  2017-01-31       Impact factor: 5.103

6.  Single-reaction genomic amplification accelerates sequencing and vaccine production for classical and Swine origin human influenza a viruses.

Authors:  Bin Zhou; Matthew E Donnelly; Derek T Scholes; Kirsten St George; Masato Hatta; Yoshihiro Kawaoka; David E Wentworth
Journal:  J Virol       Date:  2009-07-15       Impact factor: 5.103

7.  The influence of the multi-basic cleavage site of the H5 hemagglutinin on the attenuation, immunogenicity and efficacy of a live attenuated influenza A H5N1 cold-adapted vaccine virus.

Authors:  Amorsolo L Suguitan; Michael P Marino; Purvi D Desai; Li-Mei Chen; Yumiko Matsuoka; Ruben O Donis; Hong Jin; David E Swayne; George Kemble; Kanta Subbarao
Journal:  Virology       Date:  2009-10-14       Impact factor: 3.616

8.  Reversion of Cold-Adapted Live Attenuated Influenza Vaccine into a Pathogenic Virus.

Authors:  Bin Zhou; Victoria A Meliopoulos; Wei Wang; Xudong Lin; Karla M Stucker; Rebecca A Halpin; Timothy B Stockwell; Stacey Schultz-Cherry; David E Wentworth
Journal:  J Virol       Date:  2016-09-12       Impact factor: 5.103

Review 9.  Current status of live attenuated influenza vaccine in the United States for seasonal and pandemic influenza.

Authors:  Christopher S Ambrose; Catherine Luke; Kathleen Coelingh
Journal:  Influenza Other Respir Viruses       Date:  2008-11       Impact factor: 4.380

10.  An avian live attenuated master backbone for potential use in epidemic and pandemic influenza vaccines.

Authors:  Danielle Hickman; Md Jaber Hossain; Haichen Song; Yonas Araya; Alicia Solórzano; Daniel R Perez
Journal:  J Gen Virol       Date:  2008-11       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.